CIPLA1,374.00

Cipla Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMADRREDDYLUPINAPOLLOHOSPMAXHEALTHDIVISLABTORNTPHARMZYDUSLIFEMcap ₹1.11L Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt247.092.1258.0258.0
Net Debt-5,200.1-7,789.8-8,439.7-8,439.7
Total Debt/Equity0.010.000.010.01
Net Debt/Equity-0.19-0.25-0.24-0.24
Total Debt/EBITDA0.040.010.040.04
Net Debt/EBITDA-0.83-1.09-1.43-1.59
Interest Coverage (EBIT/Interest)58.3097.1085.9085.90
Total Debt/Total Capital %0.910.290.740.74
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 146%.